UBS raised the firm’s price target on Booz Allen (BAH) to $135 from $120 and keeps a Neutral rating on the shares. UBS expects above-peer exposure to drive a deceleration in FY26, but sees this as priced in with mid-single digit organic revenue and EBITDA growth still achievable, the analyst tells investors in a research note. The firm views visibility from fiscal 2026 guidance as a de-risking event.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAH:
- Booz Allen awarded $209.88M Air force task order
- Booz Allen: Strong Fundamentals and Strategic Focus Justify Buy Rating Despite Sector Challenges
- Meta Recruits Former Pentagon Officials to Secure Military Contracts
- Booz Allen selected by NGA to deliver data, analytics
- Booz Allen awarded $743.1M Air Force contract